Sipuleucel-T is indicated for:
Population group: men, only adults (18 years old or older)
Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF (Sipuleucel-T) are indicated for treatment of asymptomatic or minimally symptomatic metastatic (nonvisceral) castrate resistant prostate cancer in male adults in whom chemotherapy is not yet clinically indicated.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Sipuleucel-T is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
